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Multimodal imaging probes can provide diagnostic information combining different imaging modalities. 
Nanoparticles (NPs) can contain two or more imaging tracers that allow several diagnostic techniques 
to be used simultaneously. In this work, a complex coacervation process to produce core-shell 
completely biocompatible polymeric nanoparticles (HyCoS) for multimodal imaging applications is 
described. Innovations on the traditional coacervation process are found in the control of the reaction 
temperature, allowing a speeding up of the reaction itself, and the production of a double-crosslinked 
system to improve the stability of the nanostructures in the presence of a clinically relevant contrast 
agent for MRI (Gd-DTPA). Through the control of the crosslinking behavior, an increase up to 6 times of 
the relaxometric properties of the Gd-DTPA is achieved. Furthermore, HyCoS can be loaded with a high 
amount of dye such as ATTO 633 or conjugated with a model dye such as FITC for in vivo optical imaging. 
The results show stable core-shell polymeric nanoparticles that can be used both for MRI and for optical 
applications allowing detection free from harmful radiation. Additionally, preliminary results about the 
possibility to trigger the release of a drug through a pH effect are reported.
Despite the recent advances in the single diagnostic techniques1, the study on diagnostic technology is still con-
tinuous, and it focuses on the disparity of diseases and the type of information provided by the single techniques2. 
In this scenario fits the Multimodal Imaging because it can combine two or more techniques based on different 
physical principles allowing the integration of functional information to structural ones3, overcome limitations of 
the single diagnostic techniques and optimize therapies leading to a “personalized medicine”4. Among the multi-
modal applications, Nuclear Magnetic Resonance-Optical dual imaging modality has the principle advantage to 
be completely free from ionization rays while anatomical and molecular, physiological or metabolic information 
are provided. Magnetic Resonance Imaging (MRI) is characterized by a relatively high spatial resolution, rela-
tively no tissue penetrating limits but also it has a low sensitivity, high cost and long imaging time. Furthermore, 
recent concerns about the deposition of clinically relevant Gd-based Contrast Agents (CAs), linear and macro-
cyclic one are reported by Robert McDonald on neuroradiology5 and other publications6,7. Moreover, the recent 
opinion of the Food and Drug Administration (FDA) suggests the limiting the Gadolinium-based CAs use to 
clinical circumstances in which the additional information provided by the contrast is necessary. On the same 
course of action, a general review also has summarized the literature on gadolinium-based contrast agents8. We 
firmly believe in the importance to protect the Gadolinium, both linear and macrocyclic, and overcome the low 
specificity of the CAs. Furthermore, even if recent efforts have been done to improve the relaxivity of Gd-based 
contrast agents through the nanotechnologies, relaxivity is well below the required theoretical limits for linear 
and macrocyclic both, and the boost of the signal is still a valuable issue9–12.
Differently from MRI, Optical Imaging has a higher sensitivity; it is a multicolor Imaging which allows vis-
ualizing target biological molecules (peptides, drugs, etc.) but it presents a low spatial resolution and a poor 
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tissue penetration. Among different optical techniques, Fluorescence Molecular Tomography (FMT) produces 
quantified 3D reconstructions of fluorescence activation or concentration. In this framework, their combination 
can provide information not available typically by applying the single methodologies and allows to distinguish 
finely in different tissues within the body13. The introduction of nanotechnology has led to the development 
of many medical products including the formulation of new devices that can be used for Multimodal appli-
cations13–17. Among them, nanovectors can potentially provide early diagnosis and monitoring of therapeutic 
response18,19 and play a significant role in the dawning era of personalized medicine20–22. Nowadays, although 
many efforts are made in the development of instrumentations for multimodal imaging, this field still lacks 
biocompatible, biodegradable and FDA approved probes23. In literature, different studies about dual imaging 
MRI and Optical Imaging are reported16,24,25. In 2009, Xie et al.26 produced Iron oxide nanoparticles (IONPs) for 
Positron Emission Tomography(PET)/Near InfraRed Fluorescence(NIRF)/MRI applications labeled with Cy5.5 
dye and 64Cu-DOTA chelates. In the same period, Chen et al.27 presented the IONPs nanoparticles coated with a 
PEGylated amphiphilic triblock copolymer conjugated with a Near-Infrared Fluorescent (NIRF) dye IR-Dye800 
and with 64Cu-DOTA chelates. In 2010, Nam et al.28 reported tumor targeting nanoparticles for optical/MRI 
dual imaging based on self-assembled Glycol Chitosan (GC) which is chemically modified with 5β -Cholanic 
Acid (CA). For optical imaging, (GC-CA) is used as a chelate for Gd(III) and Cy5.5 is conjugated. Tan et al.29 
in 2011, presented a multimodal imaging system by co-encapsulating superparamagnetic iron oxides (IOs) 
and Quantum Dots (QDs) in Poly(lactic acid)-d-α tocopheryl polyethylene glycol 1000 succinate (PLA-TPGS). 
Then, in 2013 Huang et al.30 produced Mn3[Co(CN)6]2 nanocubes that can serve as MRI agents and Two-Photon 
Fluorescence (TPF). Tian et al. in 2013, reported core-shell Fe3O4-Cu9S8 nanoparticles for dual-modal imaging 
and photothermal therapy31, useful as a probe for T2. Among these different probes, those combining MRI and 
Fluorescence Molecular Tomography (FMT) imaging modalities have mainly been used to evaluate morpholog-
ical and functional changes in tumors in response to chemotherapy by monitoring tumor growth and protease 
activity32. Here, we aim to design a probe that can combine multimodal properties to improve and facilitate 
the use of integrated imaging modalities. The probe is also completely biocompatible and realized with FDA 
approved materials to promote the transition of results to preclinical and clinical Multimodal Imaging. The design 
of the probe is achieved through an intriguing modification of the traditional complex coacervation able to create 
a stable architecture and to provide impressive MRI performances and release behavior. The coacervation has 
been less explored for diagnostic applications due to its complexity although it appears to be a highly productive 
method14. Among different methods of production, we have selected the Emulsion-Coacervation process because 
of its reliability in obtaining core-shell nanosystems33. Indeed, several advantages are the enormous flexibility 
due to the numerous parameters to modify for the proper success of the reaction such as pH, temperature, ionic 
strength, polyacid/polybase ratio, polymer concentration, the molecular weight of polyelectrolytes able to control 
the thickness of the layer of coacervate and the polydispersity index34,35. Furthermore, the choice of a core/shell 
architectures allows the obtaining of highly functional materials36 with modified properties by changing either 
the ratio of the constituting materials or the core to shell size. Among several advantages offered by this approach, 
the translation of the process on a large scale, the high productivity and the high flexibility of the system are the 
most attractive. Currently, nanoparticles obtained by coacervation for applications in MRI as contrast medium 
has been evaluated to allow the increase of the signal encapsulating substances such as Gd chelates, whose free 
molecule is toxic into the body25. To date, most of the efforts have been limited to grafting contrast-enhancing 
agents to the surface of hydrophobic particles, where access to water is achievable or to enhance the delivery by 
and effective encapsulation. However, exploitation of the role of coacervation and the possibility of the Emulsion 
based Coacervation processes to boost T1 in combination with optical imaging has not been performed37,38. 
Our fundamental understanding of the Complex Coacervation Method is applied to the production of Hybrid 
Core-Shell NanoParticles (HyCoS NPs) made of a Chitosan-core and a Hyaluronic Acid-shell, and to the con-
trol of their properties for application in the MRI and Optical Imaging Field. Indeed, HyCoS NPs are designed 
to entrap rationally, a relevant clinical CA, Gd-DTPA, enhancing its MRI performances and delivering a high 
amount of an optical tracer at the high-intensity signal. These nanovectors are engineered to own these peculiar 
properties and, at the same time, preserve fundamental characteristic of the delivery (e.g. size, charge, choice of 
shape and materials)39,40. Furthermore, our efforts are made to overcome the interference of MRI agent with the 
coacervation process introducing a double crosslinking reaction, an intrachain crosslinking (between polymer 
chains of core-shell) and an interchains one (between the polymer chains of the shell), able to improve the stabil-
ity of the system. Then, using the temperature, the proposed process has been speeded up to reduce the reaction 
time and stabilize the architectures.
Results
Phase behavior of the Ch-AcOH-Water system. Our first step is devoted to the understanding of the 
phase diagram of the ternary system Water-AcOH –Ch (Fig. 1) to improve the knowledge and, therefore, the 
stability of the aqueous phase of the emulsion template. The thermodynamic system is extremely complex and 
sensitive to small changes in concentration among the components. The low solubility of the Ch creates a gap 
of miscibility that is overcome by adding the AcOH dropwise. The ternary diagram, reported in Fig. 1, is built 
analyzing the behavior of Ch at different concentrations of the AcOH solution. The red working points show the 
concentrations at which the polymer is not dissolved in the solution while the green working points display the 
complete dissolution of the polymer chains. The black line, which draws the border of miscibility gap, shows a 
scratched transition area between the two different behaviors. For a concentration of 1%wt/v, the complete disso-
lution of Ch in 5 mL of water is reached only at 2 μ l/ml of AcOH.
Preparation of the Hybrid Core-Shell Nanoparticles (HyCoS NPs). Nanoparticles are produced by 
coacervation performed at 0,1% wt/v HA, 1% wt/v Ch, 30% wt/v TPP, showing a stable behavior also in water. 
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However, when Gd-DTPA is added to the aqueous phase at the ratio 1:1 GdCA:Ch, morphologies of the nano-
particles results irreversibly compromised in water (Fig. 2). Indeed, even if the coacervation is properly occurred 
in the presence of Gd-DTPA, as observed in Fig. 2A and B reporting nanoparticles in EtOH, the spherical shape is 
not preserved in water and dissolved completely just after few minutes. This evidence shows a strong interference 
of Gd-DTPA with the crosslinking reaction that weakens the effectiveness of the coacervation. To avoid the insta-
bility of the architectures in the presence of Gd-DTPA, we have proposed the introduction of a second crosslinker, 
DVS able to create bis-sulfonyl linkage between OH groups of HA41,42. Adding the different percentage of DVS 
(8%, 16%, 24% v/v), it is noticed that there are also some regular swelling phenomena by increasing the volume 
of DVS for NPs with and without Gd-DTPA (Fig. 3A–C). Indeed, NPs maintain their structures, avoiding the 
Figure 1. Experimental determination of the Phase Diagram of the ternary system Water-Acetic Acid-
Chitosan. The Phase Diagram is obtained adding dropwise the acetic acid to the Chitosan and Water, allowing 
the complete dissolution of the polymer. The green spots (-•-) represent the working point showing the 
complete dissolution of the polymer. The line drafts the miscibility gap between the two different behaviors.
Figure 2. Morphological characterization of nanoparticles by Fe-SEM. Coacervation performed at 0,1% 
wt/v HA, 1% wt/v Chitosan, 30% TPP wt/v, Gd-DTPA:Chitosan 1:1. (A) and (B) NPs collected in EtOH while 
(C) NPs collected in water. Results clearly show that if Gd_DTPA is added to the solutions, stability of the CoA 
NPs in water is compromised and the spherical core-shell morphologies are not preserved.
www.nature.com/scientificreports/
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whole dissolving phenomena only at DVS concentration of 8%v/v (Fig. 3A). At percentage of DVS higher than 
8%v/v, (Fig. 3B and C) there is an increase in the size of the nanoparticles and the production of some irregular 
shapes. This effect is probably due to interference between DVS and the system caused by a partial reaction of the 
crosslinker with the hydroxyl –OH groups of HA (Fig. 3B and C).
FT-IR analysis. An FT-IR analysis is performed to confirm the effectiveness of the chemical reaction. Indeed, 
the favorable pH conditions reported in the literature for HA and DVS41 are not properly reached in our system, 
and an FT-IR study is conducted to investigate the interaction between the two polymers (Ch and HA) and the 
crosslinkers (TPP and DVS). In Figure S1 of the Supporting Information spectra of Ch-HA nanoparticles is shown. 
A band at 3450 cm−1 that can be attributed to –NH2 and –OH group stretching vibration in chitosan matrix is cur-
rently not detected in the spectra of HyCoS NPs particles34. The characteristic bands at 1658.64 cm−1 and 
1730.92 cm−1 is attributed to C= O group stretching vibration in the HA matrix. A new sharp peak 1641 cm−1 has 
emerged, and the 1585 cm−1 peak of –NH2 bending vibration has shifted to 1582 cm−1. Because of –NH2 bending 
vibration shifts, the features bands at 1614 cm−1 and 1405 cm−1 have shifted to 1641 cm−1 and 1377 cm−1 respec-
tively. The presentation of P= O vibration absorption at 1269 cm−1 is observed, indicating the reaction between Ch 
and TPP. The peaks at 2953.42 cm−1, 2922.48 cm−1 and 2853.39 cm−1 show the − CH interaction. The characteristic 
peaks for DVS show absorptions at 1119.76 cm−1 (S= O symmetric stretching vibrations) and 720.99 cm−1 (S–C 
stretching vibrations) and through the ether bond at 1269 cm−1 (C–O–C stretching vibrations). The DVS has an 
effect on the –OH groups of the HA chains and the favourable condition for this pH reaction is between 10 and 12. 
Furthermore, the linking between the aminic groups of Ch and the phosphoric groups of TPP and the –COOH 
groups of HA is not well promoted due to the strongly acid conditions of the chitosan-water phase. The acid state of 
the Ch phase is essential not only for the complete dissolution of the Ch in the AcOH solution but also for the 
behavior of the Ch chains. In fact, at the strongly acid condition, even if more groups are activated, they are set in a 
shape not favorable to the interaction with the TPP. On the contrary, at weak acid conditions, even if there are less 
free amine groups, they are set in a more favourable shape that allows them to interact with TPP through the 
−P O3 10
5 . To improve the stability of the polymeric NPs different percentage of the two crosslinkers are tested. As 
previously shown 10%, 20% and 30% wt/v are tested for TPP while 8%, 16%, 24% v/v are tested for DVS. The results 
show not only a different stability of NPs in water but also a variation in their size. Increasing the TPP volume from 
10% wt/v to 30% wt/v, the stability of the NPs is improved, and, at the same time, the size of the NPs decreases. The 
effect obtained in the case of DVS is completely different. In fact, an increasing of DVS percentage results in both an 
increasing of the size and the development of irregular shapes. It highlights the difficult of DVS to spread through 
the emulsion in the presence of a high concentrated oil phase. DVS concentration of 8% v/v and TPP concentration 
Figure 3. Morphological characterization of nanoparticles by FE-SEM. Coacervation performed at 0,1% 
wt/v HA, 1% wt/v Chitosan, 30% TPP wt/v, Gd-DTPA: Chitosan 1:1. NPs collected in water obtained by using 
DVS at (A) 8% v/v; (B) 16% v/v; (C) 24% v/v DVS collected in water. Panel reports how the stability of the c ore 
shell nanovectors is reached only for DVS at 8% v/v.
www.nature.com/scientificreports/
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of 30%wt/v produce the stabilization of HyCoS NPs with a size in a range from 50 nm to 200 nm preserving also the 
coacervation process. It is important to note that the percentage of TPP is also increased from 20% to 30% wt/v in 
the HA phase (pH 10–11) to reach the final pH of the reaction (pH 5). In these conditions, the final values of pH is 
about 5, making stronger the linker between the two polymers. For the final reaction at pH value lower than 5, the 
crosslinking reaction of TPP between Ch and HA is not completed because the –COOH groups of HA are not fully 
activated while at pH higher than 5, available amine groups of Ch to the reaction are reduced.
Effect of the Temperature on the coacervation step. Furthermore, to minimize the time of the coacer-
vation step, different gradients of temperature are tested (Fig. 4). The intent is to promote both the evaporation of the 
AcOH and the chemical reaction of inter and intra chains. Several isothermal profiles are studied but the formation 
of nanoparticles is only observed at 35 °C, confirming that the coacervation step correctly occurs even if the mor-
phologies are not stable in water, probably due to an uncompleted chemical reaction among the compounds. Later, 
starting with the isothermal observations, we have studied the combination of an isothermal profile with a cooling 
step. In this experiment, the demixing is visible after 5,5 h of isothermic step at 35 °C followed by a ramp at 8 °C/h 
from 35 °C to 23 °C, spending about 1.5 h to reach the final stable morphologies. It is important to note that, after the 
isothermal step, when the demixing visibly occurs, the cooling of the emulsion should be suddenly performed to avoid 
aggregation phenomena among the nanovectors. Indeed, the additional cooling step is needed to increase the stability 
of the system. A reduction of the demixing time involves a decreasing in the evaporation time of the AcOH, a faster 
coacervation reaction and an acceleration of the DVS reaction with the –OH groups on the polymer chain of HA. The 
use of temperature allows a reduction of the response times from 24 h to 6,5–7 h and it also allows a comparison regard-
ing swelling behavior with HyCoS NPs obtained at constant room Temperature, as reported in the next paragraphs. 
Images reported in Fig. 5 show nanoparticles obtained at the different demixing profile of the reaction at different 
temperatures. NPs obtained performing an Isothermal at 35 °C for 5.5 h show the best stability and a defined core-shell 
morphology (Fig. 5 -•-). In Fig. 5E, a morphological characterization of core-shell nanoparticles obtained by TEM is 
shown. In details, several nanoparticles of 70 nm produced by our standard coacervation are reported while, in Fig. 5F, 
an enlargement is displayed highlighting the entire core -shell architecture. Additional TEM images are presented in 
the supporting information (Figure S2) and a 3D representation obtained by a cryo-TEM Tomography is also available.
To assess the formation of the Core-Shell Structure, Zeta Potential measurements are also performed to 
support the morphological characterization provided by TEM images and verify the deposition of HA on the 
positively charged Chitosan Core. Results regularly show − 45 mV (Standard Deviation ± 5 mV) on the slightly 
positive surface charge of the Chitosan core alone (+ 15 mV). HyCoS NPs are negatively charged due to the dep-
osition of HA on the outer face of the Chitosan core.
Figure 4. Demixing profile of the Reaction. In the graph is shown the profile of demixing of the reaction at 
different gradients of temperature. Temperature induces a reduction of the process time from 24 h to 6.5–7 h. 
Best results are obtained performing an Isothermal at 35 °C for 5.5 h and a ramp from 35 °C to 23 °C for 1.5 h. In 
details, after the isothermal step, the reaction of coacervation occurs, and a demixing of the prepared solution 
is observed. After the demixing phase, a variation of the temperature should be suddenly performed to avoid 
aggregation phenomena and the destruction of the nanovectors. Indeed, as soon as the demixing phase occurs, 
the produced nanoparticles are unstable and a further support of temperature needed to increase the stability of 
the system.
www.nature.com/scientificreports/
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pH-sensitive behavior. Preliminary results on HyCoS NPs report a peculiar yet interesting pH-sensitive 
behavior of the nanovectors. In details, HyCoS NPs produced at room Temperature, at pH 4, maintain their 
stability until the first hour, but after this time they dissolve completely. On the contrary, at pH 7 they preserve 
their stability at all the different times (30 min, 1 h, 2 h, 3 h, 6 h, 8 h, 12 h, 24 h). Nanoparticles obtained by using 
Figure 5. SEM images of nanoparticles produced by different calorimetric profile (A–D). A (•)- Nps obtained 
performing an Isothermal at 35 °C for 5.5 h; B (□ )- Result obtained performing an Isothermal at 40 °C. No 
demixing is observed; C (Х)- Result obtained performing an Isothermal at 28 °C until demixing (after 17 h). 
D (▴)-Result obtained performing an Isothermal at 23 °C until demixing (after 20 h). After that the demixing 
occurs, a ramp to 23 °C for 1.5 h is performed to complete the separation and to stabilize the morphologies. 
Morphological characterization of nanoparticles by TEM (E–F). Core-shell Gd-DTPA-Nps obtained without 
the use of the temperature profile collected in water. (E) Nps obtained at 0,1% wt/v HA, 1% wt/v Chitosan, 30% 
TPP wt/v, Gd-DTPA: Chitosan 1:1 and 8% v/v DVS and (F) Magnification of the previous image.
www.nature.com/scientificreports/
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the cooling step do not seem to be pH-sensitive and remain stable at any pH condition until 24 hr. Further details 
are reported in Figure S3 of the Supporting Information, showing images of the different behavior of the NPs by 
changing the pH conditions.
It is well known that the HA- DVS crosslinking is basic pH-sensitive due to the ionization of the carboxyl 
group(–COOH) gives rise to anionic carboxylate(CH3COO–). Consequently, the electrostatic repulsion between 
the negatively charged groups results in dramatic swelling behavior.
Therefore, the pH-sensitive behavior can be only attributed to the swelling of the coacervation layer linked by 
anions and –COOH- that it has firstly formed on the surface of the Ch droplets.
This peculiar pH triggering could provide significant advances in the use of the vector for the treatment of 
tumor pathologies. In fact, the tumor environment, besides to being devoid of oxygen, is also characterized by an 
acid pH by an impaired operation of the lymphatic system to drainage of fluids that instead tend to accumulate 
inside the interstitial space39,43–45. First, the use of macromolecules and, later, nanocarriers is exploited to study 
the potential acidity of the tumor microenvironment to release any drugs encapsulated in the carriers directly in 
the tumor area to have a diffusion of the active agents within the tumor matrix and, therefore, performed a better 
diagnosis or therapy. In conclusion, the disruption of the NPs inside the cell greatly influences the resulting toxic 
effects. This cytotoxicity can be desired, in antitumor treatments, or more or less undesired during NPs applica-
tion for diagnostics purposes. Furthermore, an excellent cell uptake of the NPs guarantees the efficient cell MRI 
and intracellular drug delivery.
In vitro MRI. As already reported in the Materials and Method Section, ICP-MS is used to assess the con-
centration fo Gd-DTPA loading within the HyCoS NPs. This data are also useful to evaluate the relaxometric 
properties of the nanovectors. Results clearly demonstrate that a relaxation rate T1 of 1720 ms is achieved with 
20 μ M of Gd-loaded HyCoS while 100 μ M of Gd-DTPA solution is required to reach similar T1 (1724 ms) (Fig. 6). 
This effect of enhanced relaxivity potentially allows the administration of a reduced dosage of contrast medium 
keeping the same T1 signal intensity. This peculiar behavior is probably ascribable to the combination between 
the hydrophobic nature of the Ch and the hydrophilic character of the HA tuning the water exchange with the 
coordination sites of the metal chelates.
Optical Imaging and bioconjugation. Two strategies are approached to evaluate the optical imaging 
properties of the HyCoS NPs: loading of the dye within the shell and bioconjugation of the dye to the surface of 
the HyCoS NPs.
In Fig. 7, results related to the optical imaging of the nanoparticles observed under STED are reported. The 
first image (Fig. 7A) shows nanoparticles obtained by coacervation performed at 0,1% wt/v HA, 1% wt/v Ch, 30% 
TPP wt/v, Gd-DTPA: Ch 1:1, 8% v/v DVS.
Cy5 ranging from 0.1 to 1 mg/mL (633 nm) is encapsulated into the NPs while, in Fig. 7B and C, the NPs are 
bioconjugated with FITC (488 nm) via EDC/NHS reaction. In (Fig. 7D), an intensity profile of the conjugated NPs 
Figure 6. In vitro MRI. Relaxation rate distributions of: Gd-DTPA in solution at (- -)10 μ M; 60 μ M (- -), 
100 μ M (- -); and HyCoS NPs loaded with Gd-DTPA at (- -)The results show an enhancement in r1 of 6 times 
compared to the free Gd-DTPA. T1.
www.nature.com/scientificreports/
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of Fig. 7C is reported. Figure 7B and C report the fluorescence due to the conjugation of the dye exclusively on the 
shell, highlighting the non-fluorescent core not involved in the reaction. However, while the Cy5- loaded HyCoS 
NPs preserve their size and shape (Fig. 7A), an increase of the shell size is observed for the FITC-bioconjugated 
HyCoS NPs. Due to these results, we have also checked that HyCoS NPs are capable of preserving their cargo 
of Gd-DTPA as so their boosted relaxometric properties. This behavior is probably due to the interference of 
the chemical reaction with the external shell, keeping intact the chitosan core containing the Gd-DTPA. It is an 
important goal considering the relevance to candidate our product for the in vivo Integrated Multimodal Imaging.
In vitro cytotoxicity. Typically, structural alterations of NPs in aqueous solutions, in cell-culture medium, 
might also affect and change the final results of the in vitro toxicological studies. Therefore, Cytotoxicity tests are 
essential to assess preliminarily the biocompatibility of the HyCoS NPs. Nasti et al.46 suggest the cytotoxicity of the 
chitosan/TPP nanoparticle to be mostly dependent on their internalisation, which on its turn seems to be scarcely 
dependent on size and clearly dominated by surface composition/charge: indeed it is well known that positively 
charged nanoparticles are more quickly internalised than negatively charged ones and the HA-coating markedly 
reduces the nanoparticle toxicity. Results of chemical characterization studies show that the amount of covalently 
incorporated DVS into the structure of HA is largely controlled by the crosslinker concentration, thereby determin-
ing the mechanical stability and resistance against enzymatic degradation. Lai demonstrates good cytocompatibility 
of HA sheets treated with concentrations of DVS ranging from 0 to 50 mM47,48. For this study, the toxicity of HyCoS 
NPs is tested using a WST-1 assay, which is based on the conversion of a water-soluble tetrazolium salt (yellowish in 
color) to water insoluble formazan (purple color) by living cells. The WST assays have appeared to be advantageous 
over MTT because of its solubility in tissue culture medium and storage condition.
Figure 7. Optical Imaging of the nanoparticles by STED. NPs obtained at 0,1% wt/v HA, 1% wt/v Chitosan, 
30% TPP wt/v, Gd-DTPA: Chitosan 1:1, 8% v/v DVS and Gd-DTPA: (A) Gd-DTPA and 100 μ l of Cy5 1 mg/ml 
(633 nm) are encapsulated into the NPs; (B) The obtained nanoparticles are conjugated with FITC (488 nm). 
The image shows the difference between the core and the shell structure; (C) Magnification of the image 
reported in figure (B), (D) intensity profile of fluorescent Nanoparticle in (B) calculated by the Region of 
Interest method (ROI).
www.nature.com/scientificreports/
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Scalar concentrations of HyCoS NPs are tested in a range between 200 ng/mL and 100 μ g/mL. It is evidenced 
that the NPs showed no detectable cytotoxicity in vitro (Fig. 8).
Successful conditions to produce HyCoS Nanoparticles with Enhanced Multimodal proper-
ties. The described process has led to the generation of NPs with a Chitosan core and an outer shell of HA. The 
innovations of process consist of a double crosslinking, by TPP and DVS, which allows controlling the stability 
and the degradation behavior of the two chosen polymers, and a heating/cooling step of the reaction to speed up 
the coacervation process and control the swelling behavior. TPP is considered as a small ion with a triple negative 
charge which is dissolved into the HA phase, able to link the hydrophobic core of Ch to the hydrophilic shell of 
HA. On the HA side, –OH(HA) and –COOH (HA) can coexist in the tripolyphosphate solution at all pH values 
promoting the interchains reaction between the two polymers. Indeed, when the solution containing the HA 
and the TPP reaches the surface of the droplet template containing Ch and DVS, a coacervation layer has firstly 
formed on the surface of the Ch droplets, and anions and COOH (HA) reacts with caution. Simultaneously, 
the –OH groups of HA are linked by DVS, stabilizing the shell. (Fig. 9A), while TPP partially diffuses inside 
the template through the coacervation layer reaching the core and creating hydrogen bonding, linking the Ch 
core to the layer of the HA firmly (Fig. 9B). However, because HA has a molecular weight larger than the Ch, 
and Ch is a hydrophobic polymer, both HA and TPP cannot deeply penetrate the core, probably reaching only 
the surface of the Ch template. The above-reported steps are here described for the first time and represent a 
significant advance in the understanding of the control of the interference due to the presence of Gd-DTPA in 
the crosslinking reaction and the coacervation process. A unique aspect of this system also lies in the double 
crosslinking promoting both an intrachain link among HA polymer chains and interchain links among Ch and 
HA able to control the loading of Gd-DTPA and its relaxometric properties. Furthermore, the TPP is added in 
HA coacervate phase while in literature is typically added to the chitosan phase. In details, phosphoric groups 
of TPP interact with the amine groups of Ch and with –COOH and –OH groups of HA, while sulfuric groups 
of DVS links –OH groups of HA. The reverse use of the two crosslinkers is fundamental to avoid the linkage 
between the chains of HA before the coacervation reaction occurs. In fact, the DVS is not able to interact with the 
Chitosan chains while TPP can link HA chains only partially46. The pH of the single polymeric solutions is deeply 
studied to control entirely the reverse use of crosslinkers. Indeed, the pH of the Ch and HA phase are controlled 
to allow the activity of the crosslinkers only during the coacervation process and not during the preparation of 
the polymer solutions. The thermodynamics of the coacervation process can be explained in 3 steps by a ternary 
phase diagram at a specific heating/cooling step (Fig. 9C). First, referring to (Fig. 9C-I) after the preparation of 
the primary emulsion, the complete dissolution of the Ch in water is reached through the utilization of the AcOH. 
The working point is located outside of the miscibility gap that exists between water and Ch. In the second step 
(Fig. 9C-II), the Coacervation phase is added to the primary emulsion, promoting the dilution of the water phase: 
in this condition, the concentration of the AcOH solution decreases below the saturation limit. At the same time, 
keeping constant the Temperature, AcOH continues evaporating, inducing a further shifting of the working point 
in the miscibility gap, leading to the coacervation of HA on the chitosan template. In the last phase (Fig. 9C-III), 
a controlled cooling step is performed to increase the miscibility gap able to promote a faster supersaturation 
and the stability of the nanoparticle’s architecture. The obtained HyCoS NPs result stable and retain their cargo 
even after the conjugation of fluorescent molecules, making them particularly suitable for multimodal imaging 
applications. Indeed, the process conditions allow the formation of the core-shell structure while the entrap-
ment of Gd-DTPA is reached through the crosslinking reactions. The proposed approach describes the successful 
Figure 8. In vitro cytotoxicity. A549 cell viability expressed as a percentage of the value obtained with a 
concentration of hyaluronic nanoparticles in a range between 10 μ g/mL and 100 μ g/mL for three different time 
intervals. The error bars represent the standard deviations calculated from three independent experiments.
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Figure 9. Description of Double Crosslinking Reaction. (A) On the left, the ionic interaction between 
TPP and Chitosan is described; later a crosslinking between Chitosan and HA is created through the TPP, 
on the right, in the last step the crosslinking between HA and DVS is obtained. (B) Diffusion and formation 
of double-crosslinked core-shell. Schematical representation of the crosslinking at the interface between the 
core and shell structure. (C) A schematical explanation of the process by the phase diagram change. Starting 
by the considerations reported in Fig. 3 about the reactive groups, this representation reports details about 
the thermodynamic involved in the proposed coacervation process. I- After the preparation of the primary 
emulsion, disperse phase contains a homogeneous solution. Therefore, the working point represented in 
the phase diagram is located in the region of complete miscibility between water and Chitosan. II- Solution 
containing the coacervate is added to the primary emulsion, promoting the dilution of the disperse phase, 
promoting the supersaturation of the solute in the disperse phase and inducing the precipitation of the chitosan. At 
the same time keeping constant the temperature, Acetic acid continues to evaporate producing the further shifting 
of the working point into the miscibility gap. This last step will complete the formation of the chitosan template and 
the HA coacervation; III- In the final phase, a controlled cooling step is performed to increase the miscibility gap 
able to promote a faster supersaturation and to enhance the stability of the nanoparticle’s architecture.
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conditions to obtain the production of HyCoS Nanoparticles with improved MRI properties. This effect can 
be explained according to the Solomon Bloemberg model49. Indeed, in this theory, the metal complex can be 
schemed as having separate coordination spheres, the Inner Sphere (IS) and the Outer Sphere (OS) both described 
by the characteristic correlation times, such as the residence time of the coordinated water molecule (τ M), 
which in turn determines the rate of the coordinated water molecule exchanging with the bulk, and the rota-
tional correlation time (τ R), which is how quickly the contrast agent is tumbling in solution and the translational 
diffusional time (τ D), which represent the diffusion of water molecules in the bulk near to the Gd complex11,49. 
Furthermore, we have recently reported that hydrogel matrices can strongly influence the relaxation rate of the 
Gadolinium-based Contrast Agents11,49. Because of our findings, we can assert that the improved MRI perfor-
mances result from the double crosslinking able to control the entrapments of the Gd-DTPA at the Chitosan–HA 
interface and, therefore, to tune its physical characteristic parameters responsible for the relaxometric properties. 
The presented approach leverages the use of the coacervation kinetic and the crosslinking reaction, promoting 
the diffusion and exchange of the components at the interface HA-Ch and leading to a peculiar environment able 
to boost the relaxometric properties. The absence of these specific conditions will result in the absence of the MRI 
signal or even of the improved performances due to the hydrophobic nature of the Chitosan that would not allow 
the water exchange with the metal chelate, limiting its relaxivity.
Conclusions
We obtained core-shell polymer NPs, which can be encapsulated with both Gd-DTPA and a Dye for Dual 
Imaging applications through a complex coacervation that exploits an innovative double crosslinking to improve 
the stability of the nanostructure overcoming the interference of the Gd-DTPA in the coacervation process. 
Furthermore, the adjustment of the process parameters, the coacervation and chemical reaction kinetic promote 
the interpolation of the hydrophobic core with the hydrophilic shell, controlling the water exchange and, con-
sequently, the relaxation rate T1, enhancing the MRI signal at reduced concentration compared to the relevant 
clinical CAs. Furthermore, we individuated some process conditions able to develop a pH-sensitive behavior of 
the HyCoS NPs. However, further investigations are required to highlight the benefits and the drawbacks of this 
behavior and to consider the system as an effective and safe platform for theranostic nanomedicine. Future devel-
opments of this project are the upgrade of the designed nanosystem to the trimodal applications and in vivo tests. 
In particular, we aim to study our HyCoS NPs with the Fluorodeoxyglucose (18F-FDG) for Positron Emission 
Tomography (PET) and integrated MRI applications.
Method
Evaluation of the Phase behavior of the Ch-Acetic Acid-Water system. The behavior of the Ch- 
AcOH-water system is evaluated experimentally starting from 1 ml of water in which are added Ch and AcOH 
at different percentages alternatively. After each addition, the vial is stirred for 15 min. After the behavior of the 
Ch- AcOH-water system is observed, if the system resulted completely solved that point was indicated on the 
ternary diagram with a green spot, alternatively with a red one. The region, in which the behavior of the ternary 
system is only partially dissolved, is displayed with a black line to underline the difference between the two dif-
ferent behaviors.
Emulsion preparation to produce core-shell nanoparticles by complex coacervation. A 
Complex Emulsion-Coacervation is used for the production of HyCoS nanostructures. The first step consists in 
the preparation of a w/o emulsion (5%/95% v/v) used as a template. The water phase is made of an aqueous solu-
tion of Ch and AcOH 8% v/v obtained by mixing 5 ml of MilliQ water at a Ch concentration ranging from 0.1% 
wt/v to 1% wt/v. Due to the hydrophobic nature of the Ch, the greater is the percentage of AcOH in the solution; 
the lower is the gap of miscibility between Ch and water. The oil phase is obtained by dissolving the surfactant 
Span80 (0.5–1% wt/v) in 45 ml of Mineral Oil and homogenizing for 5 min at 7000 rpm (by L5MA purchased by 
Silverton). The primary emulsion, obtained by mixing both phases, is treated for 20 minutes at 7000 rpm. Then, 
the solution containing HA, as a coacervate polymer, is added dropwise and the final volume is homogenized at 
7000 rpm for further 30 min, keeping constant the Temperature at 37 °C. In a different preparation, a clinical rele-
vant Contrast Agents (CAs), Gd-DTPA, at a concentration of 18 mM, is added to the aqueous solution containing 
Ch before mixing to the oil phase. When Gd-DTPA is added to the aqueous solution, the preferred volume of 
AcOH is of 10 μ L to balance the acid nature of Gd-DTPA and to re-establish the pH conditions from 4.5 to 5 able 
to favor the activation of the –COOH group. The final concentration of Gd-DTPA within the total emulsion is 
of 1.8 mM. After the preparation of a stable primary emulsion, the coacervant phase, composed of 0.1% wt/v 
HA in a water solution of 3 ml at 30% wt/v, is added dropwise to the w/o emulsion template and homogenized 
at 7000 rpm for 30 min. The pH and temperature are continuously monitored and kept at a value ranging from 
4.5–5. Coacervation starts as soon as HA reaches the surface of the droplet template containing the chitosan 
solution. To improve the stability of the coacervate, two crosslinking agents are added to the phases. The preferred 
formulation is the addition of TPP to the coacervant phase and DVS to the aqueous phase. TPP concentration 
ranges from 20–40%wt/v increasing the pH of the coacervant phase to 10–11. The addition of DVS (8–24%v/v) to 
the aqueous phase kept the pH condition at the constant value of 4.5–5. DVS is always added to the aqueous phase 
to avoid an uncontrolled crosslinking reaction. The total formulation is stirred overnight at 300 rpm at T ambient 
until coacervation in completely occurs. Time of homogenization is also studied by stirring the w/o emulsion for 
5-10-15 or 20 min at 7000 rpm while the coacervation step is performed at 30 and 60 min at 7000 rpm. In different 
protocols, the effect of the Temperature is also tested and the coacervation step is maintained at high constant 
temperature for 6 h to promote the evaporation of the AcOH or a controlled Temperature profile is performed 
from 40 to 23 °C. To follow the development of the chemical reaction, few microliter of emulsion are collected at 
different time points and the formation of the nanoparticle is attempted by SEM.
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Evaluation of Encapsulation Efficiency and Loading Capability. To study the Encapsulation 
Efficiency (EE) and the Loading Capability (LC) of several specific dyes, Cy5, Atto 633, FITC, are alternatively 
added to the aqueous phase at concentrations ranging from 0.1 to 1 mg/mL. For the determination of the EE and 
LC the protocol proposed by Ankrum et al. is followed50. Furthermore, Induced Coupled Plasma (ICP-MS) - 
NexION 350 by Perkin Elmer is used to assess the concentration of the metal chelate in the nanoparticle suspen-
sion. Nanoparticles were suspended in a solution of deionized (DI) water at a concentration of 150.000 particles/
mL. All data were collected and processed using the Syngistix Nano Application Module. Gd was measured at m/z 
157 using a 100 μ s dwell time with no settling time.
Bioconjugation of the HyCoS NPs. 230 μ l of a solution of EDC at 70 mM and 230 μ l of a solution of NHS 
at 21 mM are added to 500 μ l of NPs to activate the carboxylic groups on the external shell of HA. After 10 min 
of stirring, 40 μ l of the selected dye are added. The conjugation reaction is kept under continuous stirring for two 
hours at room temperature. Purification protocols are performed to wash away the residual reaction components 
by dialysis or ultracentrifugation. The behavior of the NPs is observed at two different pH values: 4.3 and 7. HCl 
and NaOH are added to reach the selected pH values. In particular, 8 μ l of a solution 1 M of HCl are added to 5 ml 
of NPs to reach the pH of 4. Then, the suspension is split into 10 batches of 500 μ l and kept under continuous 
stirring for 24 h. NPs, hold at pH 4, are observed at different time points, 30 min, 1 h, 2 h, 3 h, 6 h, 8 h, 12 h, 24 h 
by SEM. Alternatively, NPs are treated at pH 7, by adding 10 μ l of a NaOH solution at 1 M to 5 ml of the aqueous 
phase containing NPs at pH value of 5.5. The observation of NPs at pH 7 is done after 30 min, 1 h, 2 h, 3 h, 6 h, 8 h, 
12 h, 24 h at SEM. The experiments are repeated in triplicate.
Characterization of HyCoS Nanoparticles. Dynamic light scattering (DLS) is used to determine nan-
oparticle size (Zeta sizer, Malvern UK). The wavelength of the laser is 633 nm and the scattering angle used is 
173°. The cuvettes used are the 12 mm square glass couvettes for 90° sizing. An ideal sample submission for DLS 
analysis has a volume of 1–2 mL. In DLS analysis, the z-Average value represented the mean value of the hydrody-
namic diameter of the particle, while the polydispersity index measured the width of the particle size distribution.
Zeta potential measurements are also performed at a temperature of 25 °C on a Zetasizer Nano ZS (Malvern, 
UK), fitted with a high-concentration zeta potential cell. Various concentrations were prepared to ensure that 
any differences in the measured electrophoretic mobilities were not due to changes in conductivity. Five repeat 
measurements on each sample were made to check the repeatability of the results obtained.
A Field Emission Scanning Electron Microscope (FE-SEM) by Zeiss, Transmission Electron Microscope 
(TEM) by FEI® in DRY, CRYO and Tomography (TOMO) modes, Confocal Microscope (STED Stimulated 
Emission Depletion) and IR spectroscopy Thermo are used to characterize morphologically and chemically the 
system. The SEM characterizations are made after 48 h of stirring withdrawing 200 μ l of the reaction and diluting 
in 50 ml of EtOH, after an ultracentrifugation (UC condition 15.000 rpm 10 min 4 °C) and after the dialysis to 
control the integrity of the nanostructures. The SEM observations are made by collecting nanoparticles on an 
ISOPORE membrane of 100 nm pore size. Nanoparticles are coated with 7 nm Au or PtPd prior observation. 
The TEM analyses are conducted both in DRY, CRYO and Tomography (TOMO) modes. In the DRY mode, the 
samples are prepared using Formvar/Carbon 200 mesh Cu Agar using 20 μ l of the suspended nanoparticles. In 
CRYO mode the samples are prepared using VITROBOT FEI coating Lacey Carbon film 200 mesh Cu Agar with 
3 μ l of nanoparticles suspension. The conditions of VITROBOT are blotting time 1 s, humidity upper than 70% 
and temperature 20 °C. Confocal Microscopy (Stimulated Emission Depletion) STED is used to evaluate the fluo-
rescence of encapsulated or conjugated NPs. The observed samples are prepared by drying 20 μ l of nanoparticles 
suspension deposited in a FluorDish. FT-IR studies are conducted to investigate the interaction among Ch, TPP 
and HA in the nanoparticles formation process. The IR analysis are obtained by measuring solid samples of raw 
Chitosan, HA and TPP while 150 μ l of HyCOs NPs are deposited on silicon wafers to avoid interference.
In Vitro MRI. Analyses with Minispec 60 mq BRUKER are performed to evaluate the relaxation times. 300 μ l 
of nanoparticles’ suspension or Gd-DTPA solution are loaded within a glass tube. The Free Induction Decay 
sequence (FID) is used to evaluate the best value of the Gain to control the saturation of the signal and measure 
and to measure T2* signal. Also, the Saturation Recovery and Inversion Recovery sequences are used to measure 
T1 signal while the Carr-Purcell sequence (CPC) to evaluate T2. The relaxation time distribution are obtained by 
CONTIN Algorithm. The relaxation spectrum is normalized on the CONTIN processing parameters. The inte-
gral of a peak corresponds therefore to the contribution of the species exhibiting this peculiar relaxation to the 
relaxation time spectrum51. Experiments are repeated at least five times.
In vitro cytotoxicity. An adenocarcinoma human alveolar basal epithelial cell line (A549) is used. The cells 
are cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf serum and L-glutamine 
(2.9 mg/ml) at 37 °C in water-saturated air supplemented with 5% CO2. For the cytotoxicity measurements, the 
cells are plated in 96-well plates for 24 h before the addition of the nanoparticles. Fresh medium, containing an 
increasing concentration of nanoparticles, obtained at room temperature, is added to each well and the cells are 
incubated for 24 h. At the end of the incubation time, the cytotoxicity of the nanoparticles is tested using a WST-1 
assay (SIGMA-ALDRICH, MI). Briefly, phosphate-buffered saline (PBS) containing WST-1 is added to each well, 
and the cells are incubated for 30 min, 1 h, 2 h, 4 h, 12 h and 24 h. Spectral absorption of the samples are measured 
at 450 nm with ELISA Reader (Biotek, Winooski, VT). The number of live cells is proportional to the amount of 
formazan produced.
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